ダウンロード数: 323
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
32_929.pdf | 714.95 kB | Adobe PDF | 見る/開く |
タイトル: | 腎細胞癌における臨床検査成績と予後との関係 |
その他のタイトル: | Tumor markers in renal cell carcinoma |
著者: | 内田, 豊昭 篠原, 克人 小林, 健一 本田, 直泰 青, 輝昭 小俣, 二也 小田島, 邦男 小柴, 健 |
著者名の別形: | Uchida, Toyoaki Shinohara, Katsuto Kobayashi, Kenichi Honda, Naoyaus Ao, Teruaki Omata, Tsuguya Odajima, Kunio Koshiba, Ken |
キーワード: | Adult Aged Aged, 80 and over Blood Sedimentation Carcinoembryonic Antigen/analysis Carcinoma, Renal Cell/blood/mortality Female Fibrinogen/analysis Haptoglobins/analysis Humans Kidney Neoplasms/blood/mortality L-Lactate Dehydrogenase/blood Male Middle Aged Prognosis |
発行日: | Jul-1986 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 32 |
号: | 7 |
開始ページ: | 929 |
終了ページ: | 940 |
抄録: | Erythrocyte sedimentation rate (ESR), lactase dehydrogenase (LDH), carcinoembryonic antigen (CEA), haptoglobin, fibrinogen, CH50, Blc-globulin (C3), B1E-globulin (C4), T-cell, B-cell and phytohemagglutinin (PHA) were evaluated in 82 patients with renal cell carcinoma. Positive rates of ESR, LDH, CEA, haptoglobin, fibrinogen, CH50, C3, C4, T-cell, B-cell and PHA were 58.9, 27.1, 33.9, 21.9, 55.8, 34.2, 33.3, 34.8, 15.3, 8.0 and 39.1%, respectively. Positive rates of all serological tests in high stage (stage III and stage IV) renal cell carcinoma were higher than those of the low stage (stage I and stage II) group. Positive rates of ESR, fibrinogen, CEA, haptoglobin, C3 and C4 in the high stage group were 86.1, 81.8, 54.1, 57.1, 53.3 and 60.0% respectively. The level of ESR, LSH, CEA, fibrinogen, haptoglobin and CH50 were significantly elevated (p less than 0.001) above the normal value. Each serological test was not significantly elevated pre- or postoperatively, but in all serological tests, postoperative values were lower than the preoperative values. ESR (less than 100 mm/hour), and CEA in the positive group correlated significantly with poor prognosis (p less than 0.005). Haptoglobin and C3 in positive group also showed a significantly poor prognosis (p less than 0.05). In conclusion ESR and fibrinogen were thought to be useful for screening renal cell carcinoma patients ESR, CEA, haptoglobin, fibrinogen and C3 for estimation of staging, and ESR, CEA, haptoglobin and C3 for estimation of prognosis. |
URI: | http://hdl.handle.net/2433/118871 |
PubMed ID: | 3776772 |
出現コレクション: | Vol.32 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。